The oxygen is running at Hospital Kilamba Kiaxi. And with it, a chapter of Angola's healthcare history has been written.
Ultra Controlo has officially commissioned the complete medical gas infrastructure at the hospital, one of Angola's most critical maternal and child health centres, in a ceremony attended by representatives of MINSA, the Angolan Ministry of Health, the United Nations Development Programme, the Hospital Direction, and Angolan partner CAFN. It was the second commissioning of what will eventually be eight, the mark of a national programme of unprecedented scope that is permanently reshaping how Angola produces, distributes, and guarantees access to medical oxygen across its hospital network.
The project was developed by the United Nations Development Programme for the Ministry of Health of the Republic of Angola and is financed by the Global Fund, with a national scope covering 8 hospitals. At Hospital Kilamba Kiaxi, a facility whose entire clinical identity is built around the care of mothers and children, the stakes of that infrastructure are immediate and measurable. Oxygen is not supplemental here. In a neonatal unit, in a labour ward, in a paediatric surgical theatre, it is the difference between survival and irreversible harm. At the centre of the installation is the ULTRAOX PSA oxygen generator, Ultra Controlo's flagship medical oxygen system, which draws ambient air and separates its components through a Pressure Swing Adsorption process to produce medical-grade oxygen at 95% purity, on-site, in real time, without interruption. It runs on an oil-free compressor, monitors CO, CO2, H2O, and all critical gas parameters continuously, operates in fully automatic mode with failsafe redundancy engineered in, and is certified under ISO 13485:2016 and compliant with both European and American Pharmacopeia standards. For a hospital of this nature, it means every clinical area draws from a source that does not run out, does not arrive late, and does not depend on road conditions, import logistics, or the fragile economics of cylinder procurement. The ULTRAOX reduces annual oxygen costs by up to 70% compared to traditional cylinder-based supply, transforming what was once a perpetual operational burden into a permanent infrastructure asset.




